Standout Papers

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb 2018 2026 2020 2023 291
  1. Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb (2018)
    Andreas Wollenberg, Michael Howell et al. Journal of Allergy and Clinical Immunology

Immediate Impact

59 standout
Sub-graph 1 of 22

Citing Papers

CellChat for systematic analysis of cell–cell communication from single-cell transcriptomics
2024 Standout
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
2 intermediate papers

Works of Rachel Moate being referenced

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
2018 Standout

Author Peers

Author Last Decade Papers Cites
Rachel Moate 9 45 112 251 208 5 317
S CHAN 5 61 179 176 122 8 355
Jeremias Antinew 2 47 95 240 171 10 322
D LEUNG 8 106 137 235 167 4 339
Julie M. Fountain 12 28 48 316 113 8 353
Inbar Zucker 11 59 53 299 136 4 347
Hiroshi Komazaki 6 70 103 292 217 9 360
William D. Boothe 7 58 61 286 177 7 346
Andrea Waldman 6 27 95 300 251 11 340
Lynda Mitchell 4 22 110 260 213 4 290
Jowita Sroka-Tomaszewska 7 51 55 227 119 2 267

All Works

Loading papers...

Rankless by CCL
2026